A high abundance of CD133 + and PDL-1 expressions in the tumor immune microenvironment, suppresses NF-κβ and Wnt/β-catenin signaling pathways in tumors, and decreases the abundance of intra-tumor Treg cells (Alahdal et al., 2018). The gene discussed is NFKB1; the disease is neoplasm.